While CD103+ cDC1s play a crucial role in initiating and enhancing antitumor immune response, their presence within tumors has been shown to be notably limited, partly due to the immunosuppressive characteristics of the tumor microenvironment46. The gene discussed is ITGAE; the disease is neoplasm.